Anzalone N - Search Results

1

Neuroimaging in patients with COVID-19: a neuroradiology expert group consensus.

Kremer S, Gerevini S, Ramos A, Lersy F, Yousry T, Vernooij MW, Anzalone N, Jäger HR. Kremer S, et al. Among authors: anzalone n. Eur Radiol. 2022 Jun;32(6):3716-3725. doi: 10.1007/s00330-021-08499-0. Epub 2022 Jan 19. Eur Radiol. 2022. PMID: 35044509 Free PMC article.

2

Intracranial vascular malformations.

Anzalone N, Scomazzoni F, Strada L, Patay Z, Scotti G. Anzalone N, et al. Eur Radiol. 1998;8(5):685-90. doi: 10.1007/s003300050460. Eur Radiol. 1998. PMID: 9601953 Review.

3

Primary brain CD30+ ALK1+ anaplastic large cell lymphoma ('ALKoma'): the first case with a combination of 'not common' variants.

Ponzoni M, Terreni MR, Ciceri F, Ferreri AJ, Gerevini S, Anzalone N, Valle M, Pizzolito S, Arrigoni G. Ponzoni M, et al. Among authors: anzalone n. Ann Oncol. 2002 Nov;13(11):1827-32. doi: 10.1093/annonc/mdf300. Ann Oncol. 2002. PMID: 12419758 Free article. Review.

4

Carotid artery stenosis: intraindividual correlations of 3D time-of-flight MR angiography, contrast-enhanced MR angiography, conventional DSA, and rotational angiography for detection and grading.

Anzalone N, Scomazzoni F, Castellano R, Strada L, Righi C, Politi LS, Kirchin MA, Chiesa R, Scotti G. Anzalone N, et al. Radiology. 2005 Jul;236(1):204-13. doi: 10.1148/radiol.2361032048. Epub 2005 Jun 13. Radiology. 2005. PMID: 15955853

5

Contrast enhancement of central nervous system lesions: multicenter intraindividual crossover comparative study of two MR contrast agents.

Maravilla KR, Maldjian JA, Schmalfuss IM, Kuhn MJ, Bowen BC, Wippold FJ 2nd, Runge VM, Knopp MV, Kremer S, Wolansky LJ, Anzalone N, Essig M, Gustafsson L. Maravilla KR, et al. Among authors: anzalone n. Radiology. 2006 Aug;240(2):389-400. doi: 10.1148/radiol.2402051266. Epub 2006 Jun 26. Radiology. 2006. PMID: 16801373 Clinical Trial.

6

Contrast-enhanced MRA of intracranial vessels.

Anzalone N. Anzalone N. Eur Radiol. 2005 Dec;15 Suppl 5:E3-10. doi: 10.1007/s10406-005-0160-3. Eur Radiol. 2005. PMID: 18637225 Review.

7

High relaxivity contrast agents in MR angiography of the carotid arteries.

Anzalone N, Scotti R, Vezzulli P. Anzalone N, et al. Eur Radiol. 2006 Nov;16 Suppl 7:M27-34. doi: 10.1007/s10406-006-0193-2. Eur Radiol. 2006. PMID: 18655264 Review.

8

Detection of cerebral metastases on magnetic resonance imaging: intraindividual comparison of gadobutrol with gadopentetate dimeglumine.

Anzalone N, Gerevini S, Scotti R, Vezzulli P, Picozzi P. Anzalone N, et al. Acta Radiol. 2009 Oct;50(8):933-40. doi: 10.1080/02841850903095385. Acta Radiol. 2009. PMID: 19626475 Clinical Trial.

9

Cerebral neoplastic enhancing lesions: multicenter, randomized, crossover intraindividual comparison between gadobutrol (1.0M) and gadoterate meglumine (0.5M) at 0.1 mmol Gd/kg body weight in a clinical setting.

Anzalone N, Scarabino T, Venturi C, Cristaudo C, Tartaro A, Scotti G, Zimatore D, Floris R, Carriero A, Longo M, Cirillo M, Cova MA, Gatti S, Voth M, Colosimo C. Anzalone N, et al. Eur J Radiol. 2013 Jan;82(1):139-45. doi: 10.1016/j.ejrad.2011.07.005. Epub 2011 Sep 3. Eur J Radiol. 2013. PMID: 21890295 Clinical Trial.

10

Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.

Santarosa C, Castellano A, Conte GM, Cadioli M, Iadanza A, Terreni MR, Franzin A, Bello L, Caulo M, Falini A, Anzalone N. Santarosa C, et al. Among authors: anzalone n. Eur J Radiol. 2016 Jun;85(6):1147-56. doi: 10.1016/j.ejrad.2016.03.020. Epub 2016 Mar 22. Eur J Radiol. 2016. PMID: 27161065

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

107 results

Search Page